What is the SAMe-TT2R2 score used for?
The SAMe-TT2R2 score is used to identify patients who are good candidates for VKA therapy. It awards 1 point for each of the following: sex (female); age <60 y; medical history (3 comorbidities: hypertension, diabetes, coronary heart disease/myocardial infarction, peripheral artery disease, heart failure, prior stroke, lung disease, liver disease or renal failure); treatments (such as amiodarone); smoking status (double); and race (non-Caucasian, double).